Skip to content

Pulse Biosciences, Inc. PLSE Intangible Amortization

Intangible Amortization at other companies

LivaNova logo
LivaNovaLIVN
$4.56M+8.3%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$562K-81.1%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$240K0.0%

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s intangible amortization?
Pulse Biosciences, Inc. (PLSE) reported intangible amortization of $167K in Q1 2026.
How has Pulse Biosciences, Inc.'s intangible amortization changed year-over-year?
Pulse Biosciences, Inc.'s intangible amortization increased by 0.6% year-over-year, from $166K to $167K.
What is the long-term trend for Pulse Biosciences, Inc.'s intangible amortization?
Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s intangible amortization has grown at a -0.0% compound annual growth rate (CAGR), from $666K to $665K.
What does intangible amortization mean?
Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.